Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
No results matched your search
Zomedica Pharmaceuticals Corp (ZOM)
Add to/Remove from a Portfolio
Add to Portfolio
1.8600
+0.0100
+0.54%
After Hours
1.9600
+0.1000
+5.3763%
0:50:11 - Real-time Data
- Volume: 56,165,688
- Bid/Ask: 1.9500 / 1.9800
- Day's Range: 1.7400 - 1.9800
Zomedica Pharma
1.8600
+0.0100
+0.54%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Overview
- Profile
- Historical Data
Prev. Close1.85
Day's Range1.74 - 1.98
RevenueN/A
Open1.75
52 wk Range0.0628 - 2.91
EPS - 0.08
Volume56,165,688
Market Cap1.74B
Dividend (Yield)N/A (N/A)
Average Volume (3m)171,251,994
P/E RatioN/A
Beta0.59
1-Year Change644.3%
Shares Outstanding933,185,839
Next Earnings DateMay 18, 2021
What is your sentiment on Zomedica Pharma?
Members' Sentiments:
or
Market is currently closed. Voting is open during market hours.
Zomedica Pharmaceuticals Corp News
Zomedica Pharmaceuticals reports Q4 results
By Seeking Alpha - Feb 26, 2021
Zomedica Pharmaceuticals (ZOM): Q4 GAAP EPS of -$0.05.Cash and equivalents of ~$62M as of Dec
CLF, ZOM among premarket losers
By Seeking Alpha - Feb 09, 2021
Infinity Pharmaceuticals (NASDAQ:INFI) -22%.Ekso Bionics EKSO -21% after stock offering.Aeterna Zentaris (NASDAQ:AEZS) -18%.Zomedica ZOM -17% after stock offering...
MARA, GME, FRSX and ZOM among midday movers
By Seeking Alpha - Jan 13, 2021
Technical Summary
| Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Sell | Neutral | Buy |
| Technical Indicators | Neutral | BUY | Strong Sell | Strong Sell | BUY |
| Summary | Neutral | Neutral | Strong Sell | Sell | Buy |
Filter Table By:
| Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
|---|---|---|---|---|---|
| Completed Patterns | |||||
| Three Outside Up | 1M | 2 | Dec 20 | ||
| Bullish Engulfing | 1M | 3 | Nov 20 | ||
| Bullish doji Star | 1M | 5 | Sep 20 | ||
| Bullish doji Star | 1M | 9 | May 20 | ||
| Three Outside Up | 30 | 9 | Feb 26, 2021 17:00 | ||
Trending Stocks
| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| UBA | 8.15 | 8.35 | 8.00 | -0.05 | -0.61% | 16.09M | 26/02 | ||
| Dangote Cement | 207.40 | 207.40 | 207.40 | -12.60 | -5.73% | 174.98K | 26/02 | ||
| Zenith Bank | 25.45 | 25.90 | 25.30 | -0.40 | -1.55% | 26.61M | 26/02 | ||
| Guaranty Trust Bank | 31.00 | 31.10 | 31.00 | -0.05 | -0.16% | 9.02M | 26/02 | ||
| ETI | 5.20 | 5.25 | 5.10 | 0.00 | 0.00% | 2.56M | 26/02 | ||
| Aiico | 1.15 | 1.15 | 1.15 | -0.05 | -4.17% | 619.30K | 26/02 | ||
| Presco | 70.00 | 71.90 | 70.55 | +1.35 | +1.91% | 767.75K | 26/02 | ||
| Champion Brew | 2.52 | 2.53 | 2.52 | -0.28 | -10.00% | 601.88K | 26/02 | ||
| Mrs | 12.95 | 12.95 | 12.95 | -0.45 | -3.36% | 0.11K | 26/02 | ||
| Cileasing | 5.60 | 5.20 | 5.20 | +0.07 | +1.36% | 1.91M | 26/02 |
Zomedica Pharmaceuticals Corp Company Profile
Zomedica Corp., formerly Zomedica Pharmaceuticals Corp., is a development stage veterinary diagnostic and pharmaceutical company. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. It is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Company’s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. It is developing ZM-017 as a canine cancer liquid biopsy platform.
Read More
Write your thoughts about Zomedica Pharmaceuticals Corp
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.